India approves Moderna’s vaccine for emergency use; Cipla to import jab
Drug major Cipla has been approved by India’s drug regulator to import Moderna’s coronavirus vaccine for restricted emergency use in the country, the government said on Tuesday. Moderna is said to have applied for the emergency use approval in India following the US agreement to donate doses to India via Covax. Cipla on behalf of the US pharma giant has requested for import and marketing authorisation of these jabs. READ MORE…
Sebi overhauls norms for appointment, removal of independent directors
The Securities and Exchange Board of India (Sebi) on Tuesday overhauled norms pertaining for appointment, removal and remuneration of independent directors (ID) in order to reduce the sway of promoters on them. The regulator also reduced the minimum application amount for REITs and InvITs to Rs 10,000-15,000, from Rs 55,000 at present,…